| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:1090.)
© 2008 American Heart Association, Inc.
Original Contributions |
From the Institute of Neurological Sciences (J.M.R.), Glasgow, UK; HealthCore, Inc (D.D.), Wilmington, Del; the Division of Neurology (G.J.G., C.C., S.J.P.), Faculty of Medicine, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada; and the Faculty of Medicine (M.K.K.), University of Toronto, Toronto, Ontario, Canada, the Division of General Internal Medicine and Clinical Epidemiology and Womens Health Program, University Health Network, Toronto, Ontario, Canada, and the Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Correspondence to John M. Reid, DPhil, Institute of Neurological Sciences, 1345 Govan Road, Glasgow, UK G51 4TF. E-mail johnmreid{at}doctors.net.uk
Background and Purpose— Studies suggest that women with stroke are investigated less aggressively and receive tissue plasminogen activator less frequently than men. We tested whether gender differences in the investigation, treatment, and outcome of stroke are due to confounding factors.
Methods— Gender differences in the use of investigations, trial enrollment, treatment with intravenous tissue plasminogen activator, and in-hospital outcomes were examined in data from our prospective registry using multivariate analysis to adjust for age, prestroke functional status, stroke subtype and severity, and atrial fibrillation.
Results— Of 2725 consecutive hospitalized patients (1996 to 2006), 88% had ischemic stroke and 48% were women. Women were older (median age, 77 versus 70 years), had more severe strokes, and were less likely to be independent prestroke (78% versus 87%) compared with men (all P<0.001). The proportion of women, but not men, aged
80 years, increased significantly between 1996 to 1997 and 2005 to 2006. After adjustment for confounding, women were less likely to have infratentorial strokes (OR, 0.78; 95% CI, 0.62 to 0.97), be able to walk unaided on admission (OR, 0.69; 95% CI, 0.54 to 0.87), be treated with tissue plasminogen activator (OR, 0.51; 95% CI, 0.35 to 0.72), experience pneumonia (OR, 0.38; 95% CI, 0.26 to 0.55), achieve a discharge Barthel Index of
95 (OR, 0.75; 95% CI, 0.61 to 0.94, and were more likely to experience a urinary tract infection (OR, 2.06; 95% CI, 1.61 to 2.64). There was no gender difference in adjusted use of investigations.
Conclusion— The majority of the gender differences in stroke were explained by confounding. More research is required to understand gender differences in stroke pathophysiology and the utilization of thrombolytic therapy.
Key Words: gender outcomes research stroke tissue plasminogen activator
This article has been cited by other articles:
![]() |
J. H. Lichtman, S. B. Jones, E. Watanabe, N. B. Allen, Y. Wang, V. J. Howard, and L. B. Goldstein Elderly Women Have Lower Rates of Stroke, Cardiovascular Events, and Mortality After Hospitalization for Transient Ischemic Attack Stroke, June 1, 2009; 40(6): 2116 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reeves, A. Bhatt, P. Jajou, M. Brown, and L. Lisabeth Sex Differences in the Use of Intravenous rt-PA Thrombolysis Treatment for Acute Ischemic Stroke: A Meta-Analysis Stroke, May 1, 2009; 40(5): 1743 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gargano, S. Wehner, and M. J. Reeves Do Presenting Symptoms Explain Sex Differences in Emergency Department Delays Among Patients With Acute Stroke? Stroke, April 1, 2009; 40(4): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
Sex Differences in IV tPA Use and Stroke Outcomes Journal Watch Neurology, December 16, 2008; 2008(1216): 2 - 2. [Full Text] |
||||
![]() |
S. Prabhakaran and M. S.V. Elkind Vive la difference!: On potential sex differences in response to thrombolysis Neurology, September 30, 2008; 71(14): 1048 - 1049. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |